Business development models

Collaborations and business development are integral to our growth strategy and have played a key role in our complex generics and biosimilars business.

 We seek partners for the following opportunities:

Out-licensing our biosimilars manufacturing technologies 

Purchase of our finished biopharmaceuticals and bulk API

Establishing  joint ventures for biosimilars production

Co-development of biopharmaceuticals